Citranatal 90 Dha label

Citranatal 90 Dha

Citranatal 90 Dha Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

Ingestion of more than 3 grams of omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including an increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis.

WARNING: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

CitraNatal® 90 DHA is a multivitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers.

History

There is currently no drug history available for this drug.

Other Information

There are no additional details available for this product.

Citranatal 90 Dha Manufacturers

  • Mission Pharmacal Company
    Citranatal 90 Dha | Mission Pharmacal Company
    No Recall

    Citranatal 90 Dha | Mission Pharmacal Company

    Citranatal 90 Dha | Mission Pharmacal Company

    One tablet and one capsule daily or as directed by a physician.

  • Mission Pharmacal Company
    Citranatal 90 Dha | Mission Pharmacal Company
    No Recall

    Citranatal 90 Dha | Mission Pharmacal Company

    Citranatal 90 Dha | Mission Pharmacal Company

    One tablet and one capsule daily or as directed by a physician.